Showing results (101-110 of 287) with videos related to
Sort By:
Pageof 29
The New Zealand Medical Journal|May 9, 1984
Intercensal trends in cigarette smoking in New Zealand 1: age, sex and ethnic statusD R Hay, F H FosterBiochemical Society Symposium|January 1, 1987
Hormonal regulation of fluxes through pyruvate dehydrogenase and the citric acid cycle in mammalian tissuesR M Denton, J G McCormack, P J Midgley, et al.Infection and Immunity|May 1, 1981
Amplified lymphokine production phenomenon confirmed by a macrophage 2-D-[3H]deoxyglucose transport assayJ G McCormack, A L Moore, J E Johnson, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytesJ R Philp, J G McCormack, A L Moore, et al.Circulation|January 1, 1996
Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat heartsJ G McCormack, R L Barr, A A Wolff, et al.Current Opinion in Drug Discovery & Development|August 4, 2009
Protein tyrosine phosphatases (PTPs) as drug targets: inhibitors of PTP-1B for the treatment of diabetesN P Møller, L F Iversen, H S Andersen, et al.Journal of Cardiovascular Pharmacology|January 1, 1988
Effects of Ca2+ on the activities of the calcium-sensitive dehydrogenases within the mitochondria of mammalian tissuesR M Denton, G A Rutter, P J Midgley, et al.Cardiovascular Research|February 1, 1997
Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventionsW C Stanley, G D Lopaschuk, J L Hall, et al.Biochemical Pharmacology|November 9, 1995
The antianginal agent ranolazine is a weak inhibitor of the respiratory complex I, but with greater potency in broken or uncoupled than in coupled mitochondriaK M Wyatt, C Skene, K Veitch, et al.Cryo Letters|July 31, 2002
Low temperature survival of slender naiad (Najas flexilis) seedsF R Hay, J SK MuirPageof 29